CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Pittsburgh, Pennsylvania, United States and 137 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Pittsburgh, Pennsylvania, United States and 67 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Scottdale, Pennsylvania, United States and 134 other locations
efficacy of lunsekimig in adult participants with moderate-to-severe asthma who have previously completed the parent study. After completion...
Phase 2
Pittsburgh, Pennsylvania, United States and 14 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 382 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Pittsburgh, Pennsylvania, United States and 419 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 361 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Pittsburgh, Pennsylvania, United States and 142 other locations
safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 161 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Pittsburgh, Pennsylvania, United States and 331 other locations
Clinical trials
Research sites
Resources
Legal